Mitochondrial Dysfunction and Apoptosis in Cumulus Cells of Type I Diabetic Mice by Wang, Qiang et al.
Mitochondrial Dysfunction and Apoptosis in Cumulus
Cells of Type I Diabetic Mice
Qiang Wang
1,2, Antonina I. Frolova
1, Scott Purcell
1, Katie Adastra
1, Erica Schoeller
1, Maggie M. Chi
1, Tim
Schedl
2, Kelle H. Moley
1*
1Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 2Department of Genetics,
Washington University School of Medicine, St. Louis, Missouri, United States of America
Abstract
Impaired oocyte quality has been demonstrated in diabetic mice; however, the potential pathways by which maternal
diabetes exerts its effects on the oocyte are poorly understood. Cumulus cells are in direct contact with the oocyte via gap
junctions and provide essential nutrients to support oocyte development. In this study, we investigated the effects of
maternal diabetes on the mitochondrial status in cumulus cells. We found an increased frequency of fragmented
mitochondria, a decreased transmembrane potential and an aggregated distribution of mitochondria in cumulus cells from
diabetic mice. Furthermore, while mitochondrial biogenesis in cumulus cells was induced by maternal diabetes, their
metabolic function was disrupted as evidenced by lower ATP and citrate levels. Moreover, we present evidence suggesting
that the mitochondrial impairments induced by maternal diabetes, at least in part, lead to cumulus cell apoptosis through
the release of cytochrome c. Together the deleterious effects on cumulus cells may disrupt trophic and signaling
interactions with the oocyte, contributing to oocyte incompetence and thus poor pregnancy outcomes in diabetic females.
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Introduction
In women, type I (insulin-dependent) diabetes has been linked to
complications during pregnancy, often resulting in miscarriage,
embryonic developmental abnormalities and congenital malforma-
tions [1]. Likewise, numerous studies have suggested that the diabetic
condition adversely affects development of pre- and post-implanta-
tion embryos in rodents [2,3,4,5]. Recently, emerging evidence has
shown that oocytes from diabetic mice experience delayed
maturation, abnormal cellular metabolism, mitochondrial dysfunc-
tion and meiotic defects [6,7,8]. These changes in the oocyte may be
manifested later as developmental abnormalities in preimplantation
embryos, congenital malformations, and even metabolic disease in
the offspring [8,9]. However, the pathway(s) by which maternal
diabetes exerts its effects on the oocyte remains ill defined.
Mammalianovarian folliclesare highly specialized structures that
support the growth and development of oocytes. Bidirectional
communication between the oocyte and companion somatic cells,
known as the granulosa cells, is essential for the development and
function of both follicular compartments [10]. In antral follicles,
there are two major types of granulosa cells that are anatomically
and functionally distinct: mural granulosa cells, which line the wall
of the follicle and play a principally steroidogenic role, and cumulus
cells, which form an intimate association with the oocyte. Cumulus
cells possess specialized trans-zonal cytoplasmic projections that
penetrate through the zona pellucida and form gap junctions at
their tips with the oocyte, generating an elaborate structure called
the cumulus-oocyte complex (COC) [11,12]. Cumulus cells have
long been known to play a nurturing role in supporting oocyte
development by providing essential nutrients to oocytes [13].
Recently, we detected abnormal metabolism, increased apoptosis
and decreased gap junction communication in granulosa cells from
diabetic mice [8,14,15,16]. Moreover, mitochondria are the
primary energy-generating system in most eukaryotic cells,
participating in intermediary metabolism and apoptosis.
Given the above findings,wehypothesized that maternal diabetes
adversely impacts the mitochondria in cumulus cells, which may be
further transferred into the oocyte, contributing to poor oocyte
quality. To test this hypothesis, we investigated the effects of
maternal diabetes on mitochondrial status in cumulus cells using
streptozotocin (STZ)-induced diabetic and Akita (insulin 2 gene
mutant) mouse models. Molecular, cellular and biochemical
analysis demonstrated structural, spatial and metabolic dysfunction
of mitochondria in cumulus cells of diabetic mice. Furthermore, we
provide evidence that mitochondrial impairments are involved in
apoptosis of cumulus cells induced by maternal diabetes.
Results
Morphological alterations of mitochondria in cumulus
cells of diabetic mice
To determine if maternal diabetes affects mitochondrial
structure in cumulus cells, transmission electron microscopy
(TEM) was performed on cumulus-oocyte complexes (COCs)
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are shown in Fig. 1. Most mitochondria in the control cumulus
cells presented as bean-shaped structures with numerous trans-
versely orientated cristae enveloped by an intact outer membrane
(Fig. 1A). In striking contrast, we observed a higher frequency of
morphological alterations in cumulus cell mitochondria from
diabetic mice (6067% vs 2569% control, p,0.05; Fig. 1D). They
displayed small spherical structures with fewer and disarrayed
cristae, and a decreased electron density of the matrix (Fig. 1B,
arrow). In addition, an increased proportion of membrane rupture
and the presence of vacuoles in mitochondria (Fig. 1C, arrow)
were found in diabetic cumulus cells as compared to controls.
These ultrastructural defects have been correlated with mitochon-
drial fission, metabolic disorders and cell death [17,18].
Decrease in mitochondrial membrane potential in
cumulus cells of diabetic mice
In light of defects in mitochondrial structure described above,
we assessed whether there was any alteration in mitochondrial
membrane potential (Dym) in cumulus cells of diabetic mice.
COCs from control and diabetic mice were stained with JC-1, a
fluorescent probe that selectively enters mitochondria and
reversibly changes color from green to red as the Dym increases
[19], and then examined by fluorescence microscopy. As shown in
Fig. 2A, mitochondria in control and diabetic cumulus cells were a
combination of both low and high membrane potential organelles,
as evident by the green and the red fluorescence. In general,
mitochondria in the control cells had predominantly high
membrane potential as indicated by the red fluorescence (Fig. 2;
arrows). However, a trend towards lower membrane potential, loss
of red fluorescence and accordingly increased green mitochondria,
was observed in the diabetic cumulus cells (Fig. 2A; arrowheads).
For quantitative analysis, we measured the intensity of red and
green fluorescence, and then the ratios of red/green were
calculated to characterize Dym. Notably, the red/green ratio
was significantly decreased in the cumulus cells of diabetic mice as
compared to those of control mice (0.7360.20 vs 1.2360.38
control, p,0.05; Fig. 2B). Such a fluorescence shift from red to
green suggests a general drop of mitochondrial membrane
potential in cumulus cells exposed to maternal diabetes.
Mitochondrial redistribution in cumulus cells of diabetic
mice
Trafficking of mitochondria is thought to be important for
mammaliancellsto be able to cater to differing energyrequirements
and provide a means for environmental sensing [20]. To determine
whether maternal diabetes affects the spatial organization of
mitochondria in cumulus cells, we compared the mitochondrial
localization between cumulus cells from control and diabetic mice.
Cells were examined by confocal microscopy following Mito-
Tracker staining. Roughly, mitochondrial distribution patterns in
the cumulus cells could be classified into two different categories: (1)
mitochondria surrounding the nucleus, termed perinuclear distri-
bution (Fig. 3Aa–d), and (2) mitochondria aggregated in parts of the
cytoplasm, termed aggregating distribution (Fig. 3Ae–h; arrow-
head). By performing quantitative analysis, we found that the
percentage of the perinuclear distribution pattern was significantly
decreased in diabetic cumulus cells relative to control (5869% vs
8165% control, p,0.05; Fig. 3B), whereas the proportion of the
aggregating distribution pattern was concomitantly increased
relative to control (4269% vs 1965% control, p,0.05; Fig. 3B).
These results indicate a redistribution of mitochondria in cumulus
cells from diabetic mice.
Increased mitochondrial biogenesis in cumulus cells of
diabetic mice
To investigate the potential effects of maternal diabetes on
mitochondrial biogenesis in cumulus cells, we first evaluated
mitochondrial DNA (mtDNA) content in cumulus cells from
control and diabetic mice by quantitative real-time PCR. Data
Figure 1. Altered mitochondrial morphology in cumulus cells
of diabetic mice. Cumulus-oocyte complexes collected from control
and diabetic mice were subjected to transmission electron microscopy
analysis and mitochondrial structure was compared. (A) Representative
electron micrograph of mitochondria from control cumulus cells,
showing bean-shaped structures with numerous transversely orientated
cristae enveloped by an intact outer membrane; (B–C) Representative
electron micrographs show alterations in mitochondrial morphology of
diabetic cumulus cells: (B) small spherical mitochondria with fewer and
disarrayed cristae and a decreased electron density of the matrix
(arrow), and (C) mitochondria with membrane rupture or large vacuoles
(arrow). Higher magnification views of boxed regions are also presented
(right panel). (D) Quantification analyses of abnormal mitochondria in
cumulus cells from control and diabetic mice. Data are presented as
mean percentage of abnormal mitochondria 6 SD in total examined
mitochondria. * p,0.05 vs control.
doi:10.1371/journal.pone.0015901.g001
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in Fig. 4A. Surprisingly, we found that mtDNA content in
cumulus cells was significantly higher in diabetic mice than in
control mice (1.6360.09 vs 1.3560.12 control; p,0.05). Further,
we measured the mRNA levels of genes implicated in
mitochondrial biogenesis, such as peroxisome proliferator-acti-
vated receptor gamma coactivator 1 alpha (PGC-1a), nuclear
respiratory factor 1 (NRF1) and mitochondrial transcription
factor A (TFAM) [21]. In agreement with elevated mtDNA
content, the cumulus cells of diabetic mice demonstrated an
approximate 2-fold increase in PGC-1aand TFAM mRNA
expression compared with those of control mice (Fig. 4B and
C). No significant difference was detected for NRF1 transcripts
(Fig. 4D). Together these data demonstrate a mitochondrial
biogenic response in cumulus cells of diabetic mice.
Metabolic dysfunction of mitochondria in cumulus cells
of diabetic mice
Given the alterations in mitochondrial structure and biogenesis,
we asked whether mitochondrial metabolism was disrupted in
cumulus cells of diabetic mice. Mitochondria generate most of
cell’s supply of ATP, and the only source of citrate in the cell is
mitochondrial tricarboxylic acid cycle (TCA) [22]. Hence, to
address the question above, cumulus cells separated from COCs of
control and diabetic mice were processed to measure ATP and
citrate levels. All metabolites are expressed as pmoles/mg DNA
(see Methods). As shown in Fig. 5, the average ATP and citrate
levels were both markedly reduced in the cumulus cells of diabetic
mice as compared to controls (ATP: 70.3619.8 vs 105.0612.2
control, p,0.05; Citrate: 17.261.7 vs 19.862.1 control, p,0.05),
suggesting a decline of mitochondrial function.
Figure 2. Decreased mitochondrial membrane potential in cumulus cells of diabetic mice. Cumulus-oocyte complexes from control and
diabetic mice were stained with JC-1 to evaluate mitochondrial membrane potential (Dym) by fluorescence microscopy. Representative images of
cumulus cells are shown. (A) Generally, mitochondria in cumulus cells of control mice were predominantly in red form (arrows), indicating the high
Dym. In contrast, the loss of red fluorescence and thus increased green mitochondria were observed in cumulus cells of diabetic mice (arrowheads),
indicating the low Dym. (B) Histogram shows the ratio of red to green fluorescence intensity calculated to characterize Dym. Note the decreased Dym
in cumulus cells of diabetic mice. Error bars indicate 6 SD. * p,0.05 vs controls. Scale bar: 20 mm.
doi:10.1371/journal.pone.0015901.g002
Figure 3. Mitochondrial distribution was disrupted in cumulus cells of diabetic mice. Cumulus-oocyte complexes collected from control
and diabetic mice were labeled with MitoTracker Red to visualize mitochondrial localization and costained with DAPI to visualize nuclei.
Representative confocal sections of cumulus cells are shown. (A) Mitochondria of most cumulus cells from control mice show perinuclear distribution
pattern (a–d). Notably, in cumulus cells from diabetic mice, aggregating distribution pattern of mitochondria was readily observed (e–h; arrowhead).
(B) Quantification of cumulus cells with each mitochondrial distribution pattern from control and diabetic mice. Data are expressed as mean
percentage 6 SD from three independent experiments in which at least 200 cells were analyzed. * p,0.05 vs control. Scale bar: 20 mm.
doi:10.1371/journal.pone.0015901.g003
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apoptosis in cumulus cells of diabetic mice
In mammalian cells, signaling cascades leading to apoptosis can
be divided into two broad groups. The intrinsic pathway (also
called mitochondrial pathway) is characterized by the central role
of mitochondria in the initiation of the caspase cascade executing
the apoptotic program. In the extrinsic pathway, caspase
activation is triggered by death receptors on the cell surface
[23]. As described above (Fig. 1 and 2), we have detected altered
mitochondrial morphology and reduced Dym in the cumulus cells
of diabetic mice. These abnormalities have been widely reported
as being sufficient to activate the apoptotic program by promoting
cytochrome c release from mitochondria into the cytoplasm
[24,25]. Thus, one possibility is that the observed mitochondrial
defects lead to cumulus cell apoptosis in diabetic mice through
cytochrome c translocation. To address this possibility, we first
evaluated apoptosis in cumulus cells from control and diabetic
mice using the TUNEL assay coupled with confocal microscopy
(Fig. 6A). Condensed chromatin (Fig. 6A; arrows) can be observed
in apoptotic cumulus cells, indicated by positive TUNEL staining.
Quantitative analysis demonstrated a significant increase in the
incidence of cumulus cell apoptosis from diabetic mice as
compared with controls (10.465.6% vs 3.061.9% control;
Fig. 6B). We next examined whether the subcellular localization
of cytochrome c was altered in those apoptotic cumulus cells from
diabetic mice using immunostaining [26]. Confocal microscopy
clearly revealed a punctate distribution pattern of cytochrome c in
control cumulus cells, which co-localized with the mitochondria-
specific dye, MitoTracker Red (Fig. 7A). However, apoptotic
cumulus cells from diabetic mice (Fig. 7B; arrows), as evidenced by
positive staining with the active caspase-3 antibody (red) and
condensed chromatin (blue) [27], always displayed a diffuse
staining of cytochrome c in the cytoplasm (green). This observation
suggests that there is cytochrome c loss from mitochondria/
translocation to the cytoplasm. Those non-apoptotic cumulus cells
of diabetic mice, which are stained negatively with the active
caspase-3 antibody, retained mitochondria-localized cytochrome c,
similar to control cells (Fig. 7B; arrowhead, lower panel). Taken
together, the co-occurrence of cytochrome c release, casapase-3
activation and apoptosis suggest that maternal diabetes induced-
apoptosis in cumulus cells is mediated, at least in part, by the
mitochondrial pathway.
Facilitative glucose transporters (GLUTs) are essential for the
glucose transport activity in cells. Glucose limitation related with
GLUT1 deficiency has been reported to result in a decrease in
mitochondrial membrane potential, cytochrome c redistribution to
cytosol, and subsequent activation of mitochondria-dependent
apoptosis [28,29]. We therefore tentatively examined GLUT1
expression and glucose uptake (File S1). We detected a dramatic
downregulation of GLUT1 protein expression (Fig. S1) and
Figure 4. Increased mitochondrial biogenesis in cumulus cells of diabetic mice. Cumulus cells removed from cumulus-oocyte complexes
were collected for analysis. (A) mtDNA content was calculated using quantitative real-time PCR by measuring the ratio of cytochrome b
(mitochondrial gene) to b-actin (nuclear gene) DNA levels in cumulus cells of control and diabetic mice. (B–D) mRNA levels of genes implicated in
mitochondrial biogenesis determined by real-time RT-PCR in cumulus cells from control and diabetic mice. At least three experiments were
performed and data are presented as the mean 6 SD of the fold changes. * p,0.05 vs control.
doi:10.1371/journal.pone.0015901.g004
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compared with controls. It is therefore possible that glucose
deprivation may trigger the mitochondrial impairments and
apoptosis in diabetic cumulus cells. Regardless, the exact
mechanisms underlying this process remain to be uncovered.
Analysis of cumulus cells from Akita genetic diabetic
model
Akita mouse, a diabetic model with spontaneous mutation of
insulin 2 gene [30], was used to test whether the abnormalities in
cumulus cells were caused by streptozotocin itself rather than
maternal diabetes. Some key phenotypes were checked and similar
results were obtained. Mitochondrial membrane potential was
dramaticallyreducedincumuluscellsfromAkitamiceincomparison
with wild type mice (Fig. S3A–B). Confocal microscopy revealed a
significantly higher percentage of apoptosis in Akita cumulus cells
than inWT(16.865.2% vs 7.764.7%WT; Fig. S4A–B). Compared
to WT, Akita mice also demonstrated the decreased GLUT1
expression (Fig. S1B) and glucose uptake (File S1; 1.8560.53 vs
2.4960.46 counts/mg protein WT; Fig. S2B) in cumulus cells.
Discussion
In the present study, we revealed alterations in morphology,
distribution, biogenesis and metabolism of mitochondria in
cumulus cells of diabetic mice, suggesting mitochondrial dysfunc-
tion. Furthermore, cumulus cells in diabetic mice undergo
apoptosis at increased frequency, likely via the mitochondrial, cell
intrinsic, pathway.
Effects of maternal diabetes on the mitochondrial status
in cumulus cells
Mitochondria are dynamic organelles, and their length, shape
and size are controlled by precisely regulated rates of fusion and
Figure 5. Reduced ATP and citrate content in cumulus cells of diabetic mice. Cumulus cells removed from cumulus-oocyte complexes were
collected to determine the levels of ATP and citrate. Values are expressed as pmoles per mg DNA. (A–B) Histogram shows the average ATP and citrate
content in cumulus cells from control and diabetic mice. All measurements were performed in triplicate. Error bars indicate 6 SD. * p,0.05 vs
controls.
doi:10.1371/journal.pone.0015901.g005
Figure 6. Increased apoptosis in cumulus cells of diabetic mice. (A) Cumulus-oocyte complexes from control and diabetic mice were stained
with TUNEL to visualize apoptotic cells (green) and counterstained with DAPI to confirm nuclear status (blue). Arrows indicate the condensed nuclei
of apoptotic cells. Representative confocal sections of cumulus cells are shown. (B) Frequency of TUNEL-positive nuclei in cumulus cells from control
and diabetic mice. Data represent mean 6 SD of three independent experiments in which at least 30 COCs were analyzed. * p,0.05 vs controls. Scale
bar: 20 mm.
doi:10.1371/journal.pone.0015901.g006
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alter the overall mitochondrial morphology [17]. Using TEM, we
observed a high frequency of mitochondrial morphological
anomalies in cumulus cells of diabetic mice, displaying small
spherical structures with fewer and disarrayed cristae (Fig. 1)—
these are often referred to as ‘‘fragmented mitochondria’’ [18].
This suggests that the maternal diabetic condition disrupts
mitochondrial dynamics in cumulus cells, resulting in greater
mitochondrial fission. Mounting evidence suggests that fusion and
fission of mitochondria affects the ability of cells to distribute their
mitochondria to specific subcellular location. For example,
mitofusins (MFN1 and MFN2) are dynamin family GTPases
known to be essential for mitochondrial fusion [32]. Aggregation
of mitochondria has been observed in cell lines expressing MFN
mutants [32,33] and MFN2-deficient neurons and myotubes
[34,35]. Remarkably, our immunofluorescent data revealed that
maternal diabetes leads to a mitochondrial redistribution in
cumulus cells. Increased mitochondrial aggregates were readily
observed in diabetic cumulus cells as compared to controls (Fig. 3).
The mechanism of such mitochondrial clusters is hypothesized to
be attributable to the formation of tethered intermediates, which
are unable to complete mitochondrial fusion, whereby ongoing
fission then leads to fragmented-tethered mitochondrial clusters
[35,36]. Furthermore, it is generally thought that trafficking of
mitochondria is important for cellular function by placing them in
appropriate locations relative to energy requiring process [20].
Hence, those fragmented and mislocated mitochondria in the
cumulus cells of diabetic mice may result in subcellular energy
depletion and even cell death [23,37,38].
Mitochondrial biogenesis is a complex process involving the
coordinate expression of mitochondrial and nuclear genes, import
of products of the latter into the organelle and turnover [39]. It has
been documented that PGC-1aregulates mitochondrial biogenesis
by serving as a coactivator of multiple transcription factors, such as
NRF and TFAM [40,41,42]. Our quantitative real-time PCR
analysis showed that mtDNA content was significantly increased in
cumulus cells from diabetic mice when compared to those from
controls. In agreement, PGC-1a and TFAM mRNAs were
upregulated in the diabetic cumulus cells (Fig. 4). To our surprise,
although mitochondrial biogenesis is stimulated, their metabolic
Figure 7. Cytochrome c translocation and caspase-3 activation in apoptotic cumulus cells of diabetic mice. (A) Cumulus-oocyte
complexes collected from control mice were stained with cytochrome c antibody and MitoTracker to determine the subcellular localization of
cytochrome c (green) and mitochondria (red), and counterstained with DAPI to visualize nuclei (blue). Representative confocal sections of cumulus
cells are shown. Cytochrome c shows a punctuate distribution pattern and co-localizes with the mitochondria (yellow) in control cumulus cells. (B)
Cumulus-oocyte complexes collected from diabetic mice were stained with cytochrome c antibody (green), activated caspase-3 antibody (red) and
DAPI (blue). All apoptotic cumulus cells of diabetic mice (arrows), as evidenced by positive staining of active caspase-3 antibody (red; arrows) and
condensed chromatin (blue; arrows), always display diffuse staining of cytochrome c (green; arrows), indicating its translocation from mitochondria to
cytoplasm. In contrast, those non-apoptotic cumulus cells of diabetic mice (green, lower panel; arrowheads) stained negatively with active caspase-3
antibody still show mitochondria-localized cytochrome c. Scale bars: 20 mm.
doi:10.1371/journal.pone.0015901.g007
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Increased mtDNA content and impaired mitochondrial function
have also been reported in several other diabetic and aged tissues
[43,44,45,46,47]. Taking into account the decreased GLUT1
expression and glucose uptake in diabetic cumulus cells (Fig. S1
and S2), we speculate that the increased mitochondrial biogenesis
may be a compensatory response to impaired glycolytic metabolism
and dysfunctional mitochondria in cumulus cells of diabetic mice.
It is known that mitochondria play diverse roles in cell
physiology and pathology including regulation of apoptosis,
participation in ion homeostasis and transport of metabolites.
These important functions are highly dependent on the trans-
membrane potential [48]. By JC-1 staining, we found that Dym
was markedly reduced in the cumulus cells of diabetic mice as
compared to control cells (Fig. 2). On the one hand, Dym has been
demonstrated to be essential for mitochondrial fusion, although
the mechanistic link between them remains to be resolved.
Ionophores that dissipate the mitochondrial membrane potential
cause mitochondrial fragmentation, owing to an inhibition of
mitochondrial fusion [49,50]. On the other hand, loss of Dym
could induce the opening of the permeability transition pore in the
inner mitochondrial membrane and consequent rupture of the
outer mitochondrial membrane, which may allow the release of
proteins that reside in the intermembrane space, including
cytochrome c, to activate the caspase cascade that executes the
apoptotic program [51,52]. In line with this notion, we found that
cytochrome c is released from the mitochondria to the cytoplasm
in all apoptotic cumulus cells of diabetic mice, coinciding with
activation of caspase-3 (Fig. 6 and 7), implicating the mitochon-
drial death pathway in maternal diabetes-induced cumulus cell
apoptosis. In addition, the potential role of mitochondrial
fragmentation and redistribution, which we observed in cumulus
cells from diabetic mice, has also been described as participating in
the control of apoptosis [25,53,54].
Collectively, our data demonstrates that maternal diabetes
induces mitochondrial dysfunction in cumulus cells, which leads,
at least in part, to an increase in apoptosis, probably by regulating
GLUT1 expression and concomitant glucose transport.
Potential effects of mitochondrial dysfunction and
apoptosis in cumulus cells on oocyte quality in diabetic
mice
Cumulus cells and the oocyte are metabolically coupled
throughout follicular development by membrane specializations
know as gap junctions [55]. It is well known that cumulus cells
support oocyte development through the provision of essential
nutrients, information molecules, metabolic precursors and
signaling molecules [56]. An important point, particularly in
relation to diabetes, is that oocytes are deficient in their ability to
use glucose as an energy substrate and require cumulus cell-
provided products of glycolysis like pyruvate for their own
development [55]. For example, only pyruvate can support oocyte
development in vitro if no cumulus cells are present. However,
when these cells are included in the culture medium glucose is also
able to support oocyte maturation [57]. Notably, pyruvate can
easily move into the mitochondrial matrix which contains
pyruvate dehydrogenase, where it enters TCA cycle generating
energy such as ATP [58]. Moreover, oocytes enclosed in cumulus
cells have higher amounts of ATP than those lacking cumulus cells
[59], suggesting that cumulus cells provide ATP for oocyte
development. Pyruvate produced as a product of glycolysis by
cumulus cells also could be transferred to oocytes via gap junction
[10]. Thus, mitochondrial function is critical for the energy
production through glycolysis and TCA cycle pathways in
cumulus cells and thereafter energy supply for oocyte maturation.
Combining our previous findings [14,16] with the results
presented here, we conclude that mitochondrial dysfunction and
the resultant apoptosis in cumulus cells may compromise the
competence of oocyte in diabetic mice through the following
possible pathways. First, reduced ATP levels in cumulus cells
(Fig. 5) and decreased oocyte-somatic cell gap junction commu-
nication may together contribute to the low ATP content we
observed in diabetic oocytes [7,8]. Such a variation in ATP
content has been suggested to significantly affect oocyte quality,
embryonic development and even the implantation process
[60,61]. Second, potential oxidative stress in the cumulus cells of
diabetic mice may create an unfavorable condition for oocyte
development. Mitochondria are the major reactive oxygen species
(ROS) generator, as well as one of the main target of ROS-
induced oxidative damage [62]. By performing DCFDA staining
on cumulus-oocyte complexes (see File S1), we found that ROS
production is significantly increased in cumulus cells from diabetic
mice when compared to those from control mice (Fig. S5A–B),
which is probably the result of glucose deprivation and
mitochondrial dysfunction [62,63,64]. mtDNA is highly suscepti-
ble to oxidative attack because of its lack of both protective
histones and DNA repair activity [65]. Thus, it is possible that
mitochondrial dysfunction give rise to oxidative stress in cumulus
cells of diabetic mice, leading to mtDNA damage. Notably,
mtDNA deletion in granulosa cells has been proposed as a factor
affecting oocyte quality of aged women [66,67]. Furthermore,
oocytes exposed to environmental oxidative stress exhibit the
accelerated aging phenomena [68]. Finally, apoptosis of cumulus
cells may compromise developmental capability of the oocyte. Gap
junction intercellular communication has been demonstrated to be
able to spread cell-injuring signals generated by cells undergoing
apoptosis into healthy neighbors [69,70,71]. Moreover, granulosa
cell apoptosis was found to be accelerated in human patients with
unexplained infertility [72]. Increased apoptosis of the surround-
ing cumulus cells has been correlated with oocyte maturation
delay and poor pregnancy outcomes [73,74,75,76]. It is therefore
possible that toxic metabolites from cumulus cells undergoing
apoptosis travels through gap junctions into the oocyte. All
together, maternal diabetes may indirectly impair oocyte compe-
tence by disrupting mitochondrial function in cumulus cells and
their communications with the oocyte.
In conclusion, our results suggest a potential mechanism by
which maternal diabetes affects oocyte quality. Together with our
previous findings detailing the mitochondrial dysfunction in
oocytes from diabetic mice [8], targeting drugs to override
conditions that lead to mitochondrial damage and/or improve
mitochondrial function may have therapeutic potential in treating
reproductive failure of diabetic females.
Materials and Methods
Ethics Statement
All mouse studies were approved by the Animal Studies
Committee at Washington University School of Medicine and
conform to the Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health. Female B6SJLF1
mice (age 20–24 days; Jackson Laboratories, Bar Harbor, ME)
were used in this research.
Generation of diabetic mice
To generate a type I diabetic model, female mice received a
single injection of streptozotocin (Sigma, St. Louis, MO) at a dose
Effects of Maternal Diabetes on Cumulus Cells
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days after injection, glucose concentration was measured from tail-
blood samples via a Hemocue B glucose analyzer (Stockholm,
Sweden). If glucose levels were greater than 300 mg/dl, the animal
was selected for use as a diabetic model. Control mice were also
randomly selected, and their blood sugar was checked to ensure
that it was less than 150 mg/dl.
Akita mice
Akita mice have an autosomal dominant mutation, resulting in
hyperglycemia and notable pancreatic b-cell dysfunction [30]. All
Akita mice (FVB.B6-Ins2Akita/MlnJ; The Jackson Laboratory,
Stock No: 006867) had glucose checked at approximately 5–7 wk
through a tail-blood sample. If glucose levels were more than
250 mg/dl, these mice were considered to have the mutation. Age
matched wild type mice were FVB/N females with glucose levels
,100 mg/dl.
Cumulus-oocyte complex retrieval
Diabetic mice and age-matched controls were superovulated
with 10 IU Pregnant Mares Serum Gonadotropin (PMSG; Sigma)
by intraperitoneal injection. 48 hours later, the ovaries were
removed and placed in a dish containing M2 medium (Sigma).
Cumulus-oocyte complexes (COCs) were obtained by manual
rupturing of antral ovarian follicles with a sterile needle. For some
experiments, cumulus cells were collected by mouth pipetting the
COCs repeatedly.
Transmission electron microscopy
For ultrastructural analysis of mitochondria, COCs were
processed for transmission electron microscopy (TEM) as
described previously [77]. Evaluations of mitochondrial morphol-
ogy were accomplished by taking TEM micrographs from
randomly selected areas of cumulus cells. To quantify the
abnormal mitochondria, for each group, 15 micrographs taken
from 15 COCs from three mice were counted in blinded fashion at
25,0006magnification.
Estimation of mitochondrial membrane potential (Dym)
in cumulus cells
Mitochondrial membrane potential was assessed using the
MitoPT-JC1 assay kit (#924; Immunochemistry, Bloomington,
MN). Briefly, COCs were incubated in assay buffer with JC-1 for
15 min at 37uC. After two washes, cells were mounted on slides
with a drop of assay buffer and then examined using fluorescence
microscope. In healthy cells with high Dym, JC-1 spontaneously
forms complexes known as J-aggregates with intense red
fluorescence. In contrast, in unhealthy cells with low Dym, JC-1
remains in the monomeric form, which shows only green
fluorescence [19]. The ratios of red/green fluorescence intensity
were calculated to characterize the Dym [78,79]. To quantify the
fluorescence intensity, 10 different regions taken from 10 COCs
were randomly selected from 10 images for each group. These
regions were measured and quantified by Image J (National
Institute of Health).
Immunofluorescence
For mitochondria localization, COCs were cultured in M2
medium containing 200 nM MitoTracker Red (Molecular Probes,
Eugene, OR) for 30 min at 37uC. Following washes, COCs were
fixed with 4% paraformaldehyde for 20 minutes and then treated
with 0.5% Triton X-100 for 20 minutes. After the brief
counterstaining with 49,69-diamidino-2-phenylindole (DAPI),
samples were analyzed by confocal microscopy (Meta 510; Carl
Zeiss, Germany).
For cytochrome c subcellular distribution, COCs were labeled
with MitoTracker Red as described above, and then fixed with 4%
paraformaldehyde for 20 minutes and permeabilized with 0.5%
Triton X-100 for 20 minutes. Followed by blocking in 1% BSA-
supplemented PBS for 1 hour, samples were incubated with
mouse monoclonal cytochrome c antibody (BD Biosciences, San
Jose, CA) overnight at 4uC. In some experiments, samples labeled
with cytochrome c antibody were also co-labeled with rabbit
polyclonal cleaved caspase-3 antibody (Cell Signaling Technology,
Danvers, MA). Alexa 488 goat anti-mouse and/or Alexa 594 goat
anti-rabbit secondary antibodies were then applied for 1 hour at
room temperature as appropriate. Nuclear status was evaluated by
DAPI staining. Samples were examined by confocal microscopy
(Meta 510; Carl Zeiss, Germany).
Determination of mtDNA content in cumulus cells
Total DNA was extracted from cumulus cells removed from
COCs using a DNeasy kit (QIAGEN, Chatsworth, CA). mtDNA
content was calculated using quantitative real-time PCR as
described previously [47,80] by measuring the threshold cycle
ratio (DCt) of a mitochondria-encoded gene (cyto b, forward 59
CCACTTCATCTTACCATTTATTATCGC, reverse 59 TTT-
TATCTGCATCTGAGTTTAATCCTGT) versus a nuclear-
encoded gene (b-actin, forward 59 CTGCCTGACGGCCAGG,
Reverse 59 CTATGGCCTCAGGAGTTTTGTC). Data are
expressed as mtDNA/nuclear DNA. All measurements were
performed in triplicate.
Real-Time RT-PCR
Cumulus cells removed from 200 COCs per group were
collected for total RNA extraction using an RNeasy kit
(QIAGEN). 200 ng of RNA was used for cDNA synthesis. Real-
time RT-PCR assay was performed according to the detailed
procedure described by Ratchford et al. [16]. Each reaction was
run in triplicate and consisted of 10 ng cDNA, 16 Power SYBR
Green PCR System (Applied Biosystem, Foster City, CA) and
4 mM forward/reverse primers. The fold change in gene
expression was calculated using the DDCt method [81] with the
house keeping gene, glyceraldehydes-3-phosphate dehydrogenase
(GAPDH), as the internal control. Primer sequences are listed
below:
PGC-1a-for: AAGTGTGGAACTCTCTGGAACTG;
PGC-1a-rev: GGGTTATCTTGGTTGGCTTTATG;
NRF1-for: CTCATCCAGGTTGGTACAGG;
NRF1-rev: GTCGTCTGGATGGTCATTTC;
TFAM-for: AATGTGGAGCGTGCTAAAAG;
TFAM-rev: AGCTGTTCTGTGGAAAATCG;
GAPDH-for: ATTGTCAGCAATGCATCCTG;
GAPDH-rev: ATGGACTGTGGTCATGAGCC.
Metabolite analytic assays
Cumulus cells removed from 100 COCs were homogenized in
10 ml 0.1N NaOH. The homogenate was heated to 80uC for
20 min, and then 5 ml of 0.15N HCl and 0.1 M Tris-HCl (pH 6.6)
cocktail was added to maintain a pH of 8.1. The samples were
stored at 280uC until the analytic assays were performed to
determine the ATP and citrate levels. Assays were designed to link
reactions ending with NAD/NADH or NADP/NADPH, which
then were enzymatically amplified in a cycling reaction, and a
byproduct of the amplification step was measured in a fluoromet-
ric assay. The detailed assay conditions are described in Chi et al.
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Terminal dUTP nick end labeling (TUNEL) assay
Cumulus cells apoptosis was evaluated using TUNEL (Roche
Molecular Biochemicals, German) as previously described [83].
COCs were fixed in 4% paraformaldehyde in PBS, permeabilized
with 0.1% Triton X-100, and then incubated in fluorescence-
labeled dUTP and terminal transferase for 1 hour at 37uC in the
dark. Nuclear DNA was counterstained with DAPI. Complexes
were visualized using confocal microscopy (Meta 510; Carl Zeiss,
Germany). Apoptosis was expressed as the percentage of TUNEL-
positive nuclei per COC. These experiments were performed in
triplicate with 10 COCs per group for each experiment.
Statistical analysis
Data are presented as mean 6 SD, unless otherwise indicated.
Statistical comparisons were made with Student’s t test and
ANOVA when appropriate. P, 0.05 was considered to be
significant.
Supporting Information
Figure S1 GLUT1 protein expression is downregulated
in cumulus cells of diabetic mice. Cumulus cells isolated
from cumulus-oocyte complexes were processed for Western blot
to analyze GLUT1 protein expression, and b-actin was used as an
internal control for loading variability. Representative Western
blots showing the decreased GLUT1 expression in cumulus cells
from (A) Streptozotocin (STZ)-induced diabetic and (B) Akita mice
compared to their controls.
(TIF)
Figure S2 Decreased glucose uptake in cumulus cells of
diabetic mice. Glucose uptake was measured in cumulus cells
from (A) control/STZ-induced diabetic and (B) WT/Akita mice,
respectively, and each sample was normalized to total protein.
Error bars indicate 6 SD. * p,0.05.
(TIF)
Figure S3 Reduced mitochondrial membrane potential
in cumulus cells of Akita mice. Cumulus-oocyte complexes
(COCs) from wild type and Akita mice were stained with JC-1 to
evaluate mitochondrial membrane potential (Dym) by fluorescence
microscopy. Representative images are shown. (A) Mitochondria
in WT cumulus cells were predominantly in red form, indicating
the high Dym. The loss of red fluorescence and increased green
mitochondria were observed in Akita cumulus cells. (B) Histogram
shows the ratio of red to green fluorescence intensity calculated to
characterize Dym. Note the decreased Dym in Akita cumulus cells.
Error bars indicate 6 SD. * p,0.05. Scale bar: 20 mm.
(TIF)
Figure S4 Increased apoptosis in cumulus cells of Akita
mice. (A) Cumulus-oocyte complexes from wild type and Akita
mice were stained with TUNEL to visualize apoptotic cells (red)
and counterstained with DAPI to visualize nuclei (blue).
Representative confocal sections of cumulus cells are shown. (B)
Frequency of TUNEL-positive nuclei in cumulus cells from WT
and Akita mice. Data represent mean 6 SD of three independent
experiments in which at least 30 COCs were analyzed. * p,0.05.
(TIF)
Figure S5 Increased ROS production in cumulus cells of
diabetic mice. (A) Cumulus-oocyte complexes (COCs) from
control and STZ-induced diabetic mice were stained with
DCFDA to determine ROS production by fluorescence micros-
copy. Representative images are shown. (B) Histogram shows the
increased fluorescence intensity in cumulus cells of diabetic mice.
Error bars indicate 6 SD. * p,0.05. Scale bar: 20 mm.
(TIF)
File S1 Additional materials and methods.
(DOC)
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